Takeda Pharma Ups Commitment to China

Takeda Pharma of Japan has signed an agreement with China Medical City in Taizhou. The company’s China subsidiary will build facilities in CMC, including buildings for R&D, manufacturing and marketing of innovative drugs. The company candidly admits it is playing catch-up in China. “We missed the boat several times in China,” said Yasuchika Hasegawa, President of Takeda, last year. “We are trying to catch the last boat.” More details.... Stock Symbol: (TSE: 4502)     Share this with colleagues:   var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});